Your browser doesn't support javascript.
loading
[Breast implant-associated anaplastic large cell lymphoma. Case report of an undiagnosed form, management and reconstruction (ALCL)]. / Lymphome anaplasique à grandes cellules associé aux implants mammaires (LAGC-AIM). Présentation clinique d'une forme initialement non-diagnostiquée, prise en charge et reconstruction.
Alhamad, S; Guerid, S; El Fakir, E H; Biron, P; Tourasse, C; Delay, E.
Afiliación
  • Alhamad S; Unité de chirurgie plastique et reconstructrice, centre Léon-Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France.
  • Guerid S; Unité de chirurgie plastique et reconstructrice, centre Léon-Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France. Electronic address: s.guerid@bluewin.ch.
  • El Fakir EH; Unité de chirurgie plastique et reconstructrice, centre Léon-Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France.
  • Biron P; Département d'oncologie médicale, centre Léon-Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France.
  • Tourasse C; Hôpital privé Jean-Mermoz, 55, avenue Jean-Mermoz, 69008 Lyon, France.
  • Delay E; Unité de chirurgie plastique et reconstructrice, centre Léon-Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France; Cabinet privé, 50, rue de la République, 69002 Lyon, France. Electronic address: Emmanuel.delay@lyon.unicancer.fr.
Ann Chir Plast Esthet ; 61(3): 223-30, 2016 Jun.
Article en Fr | MEDLINE | ID: mdl-27107559
Breast implant-associated anaplastic large cell lymphoma (ALCL) is an extremely rare disease. Is a new nosologic entity with a multifactorial origin and a wide occurrence delay after breast implantation. This article reports the case of a 60 years old patient with a progressive swelling of the right breast after aesthetic breast implants. Diagnostic was delayed because first surgeon was not familiar with the disease. Patient was then referred to us for management. We performed an implant removal and a complete capsulectomy. Pathologic report confirms the diagnostic. After one year and normal ultrasound evaluation, we reconstructed the breast with lipomodeling and mastopexy. Contralateral implant was also removed at time of reconstruction. Vast majority of breast implant-associated ALCL occurs at a time lapse of 11 to 15 years after implant augmentation, with a mean age of 63 years. Among the worldwide 173 cases reported in March 2015, smooth implants seem not to be at risk but 80% of cases were associated with macrotexturized implants. Clinical presentation and diagnostic tools are more and more published but there is to date no recommendation concerning reconstruction delay after implant removal for this pathology. We advise the realization of a breast ultrasound every three months during the first year and wait for a one-year period before reconstruction. In case of aesthetic surgery, mastopexia can be done to allow for glandular shaping. Lipomodeling is an excellent technique to correct the lack of volume due to implant removal. In case of reconstructive setting, implant can be replaced by flap procedure with lipomodeling if needed or lipomodeling alone if recipient site is favorable and patient has enough fat tissue. Contralateral implant should be removed during reconstruction time.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfoma Anaplásico de Células Grandes / Implantes de Mama Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: Fr Revista: Ann Chir Plast Esthet Año: 2016 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfoma Anaplásico de Células Grandes / Implantes de Mama Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: Fr Revista: Ann Chir Plast Esthet Año: 2016 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Francia